Crossmark

Synthesis and Biological Evaluation of Novel 1-(5-Phenyl-1,3,4-oxadiazol-2-yl)methyl-3-(4-phenylthiazol-2-yl)-1,8-naphthyridin-2(1H)-one Derivatives

Published Online: 2025-09-10

Published Print: 2025-08

Authors

Kasaboina, K. P.

Shireesha, K.

Jella, K. S. https://orcid.org/0009-0009-6240-811X
License Information

Text and Data Mining valid from 2025-08-01

Version of Record valid from 2025-08-01
More Information

Article History

Received: 17 April 2025

Revised: 21 May 2025

Accepted: 23 May 2025

First Online: 10 September 2025

CONFLICT OF INTEREST

: The authors of this work declare that they have no conflicts of interest.

Document is current